Physical Characterization and In Vitro Biological Impact of Highly Aggregated Antibodies Separated into Size-Enriched Populations by Fluorescence-Activated Cell Sorting

被引:52
作者
Telikepalli, Srivalli [1 ]
Shinogle, Heather E. [2 ]
Thapa, Prem S. [2 ]
Kim, Jae Hyun [1 ]
Deshpande, Meghana [3 ]
Jawa, Vibha [3 ]
Middaugh, C. Russell [1 ]
Narhi, Linda O. [4 ]
Joubert, Marisa K. [4 ]
Volkin, David B. [1 ]
机构
[1] Univ Kansas, Macromol & Vaccine Stabilizat Ctr, Dept Pharmaceut Chem, Lawrence, KS 66047 USA
[2] Univ Kansas, Microscopy & Analyt Imaging Lab, Lawrence, KS 66045 USA
[3] Amgen Inc, Dept Clin Immunol, Thousand Oaks, CA 91320 USA
[4] Amgen Inc, Dept Proc Dev, Thousand Oaks, CA 91320 USA
关键词
proteins; protein aggregation; particles; monoclonal antibody; IgG; immune response; immunogenicity; PBMC; in vitro; HUMAN GROWTH-HORMONE; HUMAN INTERFERON-BETA; IMMUNE TOLERANT MICE; THERAPEUTIC PROTEINS; STRUCTURAL-CHARACTERIZATION; IMMUNOGENICITY RISK; MONOCLONAL-ANTIBODY; TRANSGENIC MICE; FLOW-CYTOMETRY; WILD-TYPE;
D O I
10.1002/jps.24379
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An IgG2 monoclonal antibody (mAb) solution was subjected to stirring, generating high concentrations of nanometer and subvisible particles, which were then successfully size-enriched into different size bins by low-speed centrifugation or a combination of gravitational sedimentation and fluorescence-activated cell sorting (FACS). The size-fractionated mAb particles were assessed for their ability to elicit the release of cytokines from a population of donor-derived human peripheral blood mononuclear cells (PBMC) at two phases of the immune response. Fractions enriched in nanometer-sized particles showed a lower response than those enriched in micron-sized particles in this assay. Particles of 5-10 m in size displayed elevated cytokine release profiles compared with other size ranges. Stir-stressed mAb particles had amorphous morphology, contained protein with partially altered secondary structure, elevated surface hydrophobicity (compared with controls), and trace levels of elemental fluorine. FACS size-enriched the mAb particle samples, yet did not notably alter the overall morphology or composition of particles as measured by microflow imaging, transmission electron microscopy, and scanning electron microscopy-energy dispersive X-ray spectroscopy. The utility and limitations of FACS for size separation of mAb particles and potential of in vitroPBMC studies to rank-order the immunogenic potential of various types of mAb particles are discussed. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:1575-1591, 2015
引用
收藏
页码:1575 / 1591
页数:17
相关论文
共 64 条
[21]   Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays [J].
Jaber, Amer ;
Baker, Matthew .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (04) :1256-1261
[22]   How to systematically evaluate immunogenicity of therapeutic proteins - regulatory considerations [J].
Jahn, Eva-Maria ;
Schneider, Christian K. .
NEW BIOTECHNOLOGY, 2009, 25 (05) :280-286
[23]   Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens [J].
Johansen, P ;
Senti, G ;
Gómez, JMM ;
Wüthrich, B ;
Bot, A ;
Kündig, TM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (12) :3591-3598
[24]   Models for evaluation of relative immunogenic potential of protein particles in biopharmaceutical protein formulations [J].
Johnson, Richard ;
Jiskoot, Wim .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (10) :3586-3592
[25]   Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses [J].
Joubert, Marisa K. ;
Hokom, Martha ;
Eakin, Catherine ;
Zhou, Lei ;
Deshpande, Meghana ;
Baker, Matthew P. ;
Goletz, Theresa J. ;
Kerwin, Bruce A. ;
Chirmule, Naren ;
Narhi, Linda O. ;
Jawa, Vibha .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (30) :25266-25279
[26]   Classification and Characterization of Therapeutic Antibody Aggregates [J].
Joubert, Marisa K. ;
Luo, Quanzhou ;
Nashed-Samuel, Yasser ;
Wypych, Jette ;
Narhi, Linda O. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (28) :25118-25133
[27]   Calculating the Mass of Subvisible Protein Particles with Improved Accuracy Using Microflow Imaging Data [J].
Kalonia, Cavan ;
Kumru, Ozan S. ;
Prajapati, Indira ;
Mathaes, Roman ;
Engert, Julia ;
Zhou, Shuxia ;
Middaugh, C. Russell ;
Volkin, David B. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (02) :536-547
[28]   Radar Chart Array Analysis to Visualize Effects of Formulation Variables on IgG1 Particle Formation as Measured by Multiple Analytical Techniques [J].
Kalonia, Cavan ;
Kumru, Ozan S. ;
Kim, Jae Hyun ;
Middaugh, C. Russell ;
Volkin, David B. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (12) :4256-4267
[29]   Improved data visualization techniques for analyzing macromolecule structural changes [J].
Kim, Jae Hyun ;
Iyer, Vidyashankara ;
Joshi, Sangeeta B. ;
Volkin, David B. ;
Middaugh, C. Russell .
PROTEIN SCIENCE, 2012, 21 (10) :1540-1553
[30]   Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein [J].
Koren, E. ;
De Groot, A. S. ;
Jawa, V. ;
Beck, K. D. ;
Boone, T. ;
Rivera, D. ;
Li, L. ;
Mytych, D. ;
Koscec, M. ;
Weeraratne, D. ;
Swanson, S. ;
Martin, W. .
CLINICAL IMMUNOLOGY, 2007, 124 (01) :26-32